Evidence map›Paper›PMID 17174975›Full record

ReviewJournal of molecular and cellular cardiology2007

eNOS phosphorylation: a pivotal molecular switch in vasodilation and cardioprotection?

Rakesh C Kukreja, Lei Xi

Abstract readCommentEditorialReview
In one paragraph

Review in Journal of molecular and cellular cardiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Dietary phosphorus acutely impairs endothelial function.Journal of the American Society of Nephrology : JASN · 2009
    Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Utility of NO and HNitric oxide : biology and chemistry · 2022
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Rakesh C Kukreja
Lei Xi

Funding

Protection against Doxorubicin-Induced CardiomyopathyR37HL051045 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C · 2006 to 2015
$3.8M
CARDIOPROTECTIVE EFFECTS OF PDE-5 INHIBITORSR01HL079424 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C · 2005 to 2013
$3.6M
MOLECULAR MECHANISMS OF DELAYED PRECONDITIONINGR01HL059469 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C. · 1998 to 2006
$2.4M
SIGNALING MECHANISMS IN PHARMACOLOGICAL PRECONDITIONINGR01HL051045 · NHLBI · VIRGINIA COMMONWEALTH UNIVERSITY · PI KUKREJA, RAKESH C. · 1995 to 2004
$1.4M
NHLBI NIH HHS HL 51045NHLBI NIH HHS HL 59469NHLBI NIH HHS HL 79424NHLBI NIH HHS R01 HL051045NHLBI NIH HHS R01 HL059469NHLBI NIH HHS R01 HL079424NHLBI NIH HHS R37 HL051045
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

VasodilationEndothelium, VascularMyocytes, CardiacNitric OxideNitric Oxide Synthase Type IIIPhosphorylationNitric OxideNitric Oxide Synthase Type IIINOS3 protein, human

Identifiers

PMID17174975
PMCPMC3031790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.